Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + BUCY vs BUCY for Myeloid Tumors
NCT04098653Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Sep 2019
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT04098653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098653.